Copyright Reports & Markets. All rights reserved.

Global Angiotensin II Receptor Blockers Market Opportunities and Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Angiotensin II Receptor Blockers Market Status and Forecast (2017-2028)
      • 1.3.2 Global Angiotensin II Receptor Blockers Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Angiotensin II Receptor Blockers Supply by Company

    • 2.1 Global Angiotensin II Receptor Blockers Sales Volume by Company
    • 2.2 Global Angiotensin II Receptor Blockers Sales Value by Company
    • 2.3 Global Angiotensin II Receptor Blockers Price by Company
    • 2.4 Angiotensin II Receptor Blockers Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Angiotensin II Receptor Blockers Market Status by Type

    • 3.1 Angiotensin II Receptor Blockers Type Introduction
      • 3.1.1 Azilsartan
      • 3.1.2 Candesartan
      • 3.1.3 Eprosartan
      • 3.1.4 Irbesartan
      • 3.1.5 Losartan
      • 3.1.6 Olmesartan
      • 3.1.7 Telmisartan
      • 3.1.8 Valsartan
    • 3.2 Global Angiotensin II Receptor Blockers Market by Type
      • 3.2.1 Global Angiotensin II Receptor Blockers Sales Volume by Type (2017-2022)
      • 3.2.2 Global Angiotensin II Receptor Blockers Sales Value by Type (2017-2022)
      • 3.2.3 Global Angiotensin II Receptor Blockers Price by Type (2017-2022)
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Angiotensin II Receptor Blockers Market Status by Application

    • 4.1 Angiotensin II Receptor Blockers Segment by Application
      • 4.1.1 Chronic Kidney Diseases
      • 4.1.2 Heart Failure
      • 4.1.3 Kidney Failure in Diabetes
    • 4.2 Global Angiotensin II Receptor Blockers Market by Application
      • 4.2.1 Global Angiotensin II Receptor Blockers Sales Volume by Application (2017-2022)
      • 4.2.2 Global Angiotensin II Receptor Blockers Sales Value by Application (2017-2022)
      • 4.2.3 Global Angiotensin II Receptor Blockers Price by Application (2017-2022)
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Angiotensin II Receptor Blockers Market Status by Region

    • 5.1 Global Angiotensin II Receptor Blockers Market by Region
      • 5.1.1 Global Angiotensin II Receptor Blockers Sales Volume by Region
      • 5.1.2 Global Angiotensin II Receptor Blockers Sales Value by Region
    • 5.2 North America Angiotensin II Receptor Blockers Market Status
    • 5.3 Europe Angiotensin II Receptor Blockers Market Status
    • 5.4 Asia Pacific Angiotensin II Receptor Blockers Market Status
    • 5.5 Central & South America Angiotensin II Receptor Blockers Market Status
    • 5.6 Middle East & Africa Angiotensin II Receptor Blockers Market Status

    6 North America Angiotensin II Receptor Blockers Market Status

    • 6.1 North America Angiotensin II Receptor Blockers Market by Country
      • 6.1.1 North America Angiotensin II Receptor Blockers Sales Volume by Country (2017-2022)
      • 6.1.2 North America Angiotensin II Receptor Blockers Sales Value by Country (2017-2022)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Angiotensin II Receptor Blockers Market Status

    • 7.1 Europe Angiotensin II Receptor Blockers Market by Country
      • 7.1.1 Europe Angiotensin II Receptor Blockers Sales Volume by Country (2017-2022)
      • 7.1.2 Europe Angiotensin II Receptor Blockers Sales Value by Country (2017-2022)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Angiotensin II Receptor Blockers Market Status

    • 8.1 Asia Pacific Angiotensin II Receptor Blockers Market by Country
      • 8.1.1 Asia Pacific Angiotensin II Receptor Blockers Sales Volume by Country (2017-2022)
      • 8.1.2 Asia Pacific Angiotensin II Receptor Blockers Sales Value by Country (2017-2022)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Angiotensin II Receptor Blockers Market Status

    • 9.1 Central & South America Angiotensin II Receptor Blockers Market by Country
      • 9.1.1 Central & South America Angiotensin II Receptor Blockers Sales Volume by Country (2017-2022)
      • 9.1.2 Central & South America Angiotensin II Receptor Blockers Sales Value by Country (2017-2022)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Angiotensin II Receptor Blockers Market Status

    • 10.1 Middle East & Africa Angiotensin II Receptor Blockers Market by Country
      • 10.1.1 Middle East & Africa Angiotensin II Receptor Blockers Sales Volume by Country (2017-2022)
      • 10.1.2 Middle East & Africa Angiotensin II Receptor Blockers Sales Value by Country (2017-2022)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Angiotensin II Receptor Blockers Manufacturing Cost Analysis
    • 11.5 Angiotensin II Receptor Blockers Sales Channel and Distributors Analysis
      • 11.5.1 Angiotensin II Receptor Blockers Sales Channel
      • 11.5.2 Angiotensin II Receptor Blockers Distributors
    • 11.6 Angiotensin II Receptor Blockers Downstream Major Buyers

    12 Global Angiotensin II Receptor Blockers Market Forecast by Type and by Application

    • 12.1 Global Angiotensin II Receptor Blockers Sales Volume and Sales Value Forecast (2023-2028)
    • 12.2 Global Angiotensin II Receptor Blockers Forecast by Type
      • 12.2.1 Global Angiotensin II Receptor Blockers Sales Volume Forecast by Type
      • 12.2.2 Global Angiotensin II Receptor Blockers Sales Value Forecast by Type
      • 12.2.3 Global Angiotensin II Receptor Blockers Price Forecast by Type
    • 12.3 Global Angiotensin II Receptor Blockers Forecast by Application
      • 12.3.1 Global Angiotensin II Receptor Blockers Sales Volume Forecast by Application
      • 12.3.2 Global Angiotensin II Receptor Blockers Sales Value Forecast by Application
      • 12.3.3 Global Angiotensin II Receptor Blockers Price Forecast by Application

    13 Global Angiotensin II Receptor Blockers Market Forecast by Region/Country

    • 13.1 Global Angiotensin II Receptor Blockers Market Forecast by Region (2023-2028)
      • 13.1.1 Global Angiotensin II Receptor Blockers Sales Volume Forecast by Region (2023-2028)
      • 13.1.2 Global Angiotensin II Receptor Blockers Sales Value Forecast by Region (2023-2028)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Teva
      • 14.1.1 Company Information
      • 14.1.2 Angiotensin II Receptor Blockers Product Introduction
      • 14.1.3 Teva Angiotensin II Receptor Blockers Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.1.4 SWOT Analysis
    • 14.2 Sun Pharmaceutical
      • 14.2.1 Company Information
      • 14.2.2 Angiotensin II Receptor Blockers Product Introduction
      • 14.2.3 Sun Pharmaceutical Angiotensin II Receptor Blockers Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.2.4 SWOT Analysis
    • 14.3 Novartis
      • 14.3.1 Company Information
      • 14.3.2 Angiotensin II Receptor Blockers Product Introduction
      • 14.3.3 Novartis Angiotensin II Receptor Blockers Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.3.4 SWOT Analysis
    • 14.4 Mylan
      • 14.4.1 Company Information
      • 14.4.2 Angiotensin II Receptor Blockers Product Introduction
      • 14.4.3 Mylan Angiotensin II Receptor Blockers Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.4.4 SWOT Analysis
    • 14.5 Merck & Co.
      • 14.5.1 Company Information
      • 14.5.2 Angiotensin II Receptor Blockers Product Introduction
      • 14.5.3 Merck & Co. Angiotensin II Receptor Blockers Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.5.4 SWOT Analysis
    • 14.6 GlaxoSmithKline
      • 14.6.1 Company Information
      • 14.6.2 Angiotensin II Receptor Blockers Product Introduction
      • 14.6.3 GlaxoSmithKline Angiotensin II Receptor Blockers Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.6.4 SWOT Analysis
    • 14.7 Bayer
      • 14.7.1 Company Information
      • 14.7.2 Angiotensin II Receptor Blockers Product Introduction
      • 14.7.3 Bayer Angiotensin II Receptor Blockers Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.7.4 SWOT Analysis
    • 14.8 AstraZeneca
      • 14.8.1 Company Information
      • 14.8.2 Angiotensin II Receptor Blockers Product Introduction
      • 14.8.3 AstraZeneca Angiotensin II Receptor Blockers Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.8.4 SWOT Analysis

    15 Conclusion

      16 Methodology

      This report provides a comprehensive analysis of current global Angiotensin II Receptor Blockers market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Angiotensin II Receptor Blockers industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

      According to this survey, the global Angiotensin II Receptor Blockers market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.

      Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Angiotensin II Receptor Blockers Market Opportunties and Forecast 2022-2028 report makes a brilliant attempt to unveil key opportunities available in the global Angiotensin II Receptor Blockers market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

      The Global Angiotensin II Receptor Blockers Market has been exhibited in detail in the following chapters
      Chapter 1 displays the basic product introduction and market overview.
      Chapter 2 provides the competition landscape of global Angiotensin II Receptor Blockers industry.
      Chapter 3 provides the market analysis by type and by region
      Chapter 4 provides the market analysis by application and by region
      Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
      Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
      Chapter 12 provides the market forecast by type and by application
      Chapter 13 provides the market forecast by region
      Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
      Chapter 15 conclusions

      Segmented by Type
      Azilsartan
      Candesartan
      Olmesartan
      Telmisartan
      Valsartan

      Segmented by Application
      Chronic Kidney Diseases
      Heart Failure
      Kidney Failure in Diabetes

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Novartis
      Mylan
      Merck & Co.
      GlaxoSmithKline
      Bayer
      AstraZeneca
      Buy now